(Q37978120)

26 August 2017

title

Positive muscle phenomena--diagnosis, pathogenesis and associated disorders (English)

1 reference

26 August 2017

2

Jan H Veldink

1 reference

26 August 2017

Hans G Kortman

1

1 reference

26 August 2017

Gea Drost

series ordinal

3

1 reference

26 August 2017

language of work or name

English

0 references

publication date

24 January 2012

1 reference

26 August 2017

published in

Nature Reviews Neurology

1 reference

26 August 2017

volume

8

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

97-107

1 reference

Spasticity, an impairment that is poorly defined and poorly measured

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Windup of flexion reflexes in chronic human spinal cord injury: a marker for neuronal plateau potentials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

The spinal pathophysiology of spasticity--from a basic science point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Neurophysiological methods for the assessment of spasticity: the Hoffmann reflex, the tendon reflex, and the stretch reflex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Spasticity: clinical perceptions, neurological realities and meaningful measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

The stiff man and stiff man plus syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

A critical update on the immunopathogenesis of Stiff Person Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Stiff man syndrome with thymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Stiff man syndrome and related conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Satoyoshi syndrome has antibody against brain and gastrointestinal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Improvement of Satoyoshi syndrome with tacrolimus and corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Glutamic acid decarboxylase antibodies in Satoyoshi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Local tetanus: a case report with electrophysiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Narrative review: tetanus-a health threat after natural disasters in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

SV2 mediates entry of tetanus neurotoxin into central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Resurrection of vitamin D deficiency and rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Hypomagnesaemia of hereditary renal origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Phenotypic variants of autoimmune peripheral nerve hyperexcitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Myokymia and neuromyotonia 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Acquired neuromyotonia: a new autoantibody-mediated neuronal potassium channelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Electrophysiological studies in a mouse model of Schwartz-Jampel syndrome demonstrate muscle fiber hyperactivity of peripheral nerve origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Basement membrane proteoglycans: from cellar to ceiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Fasciculations: what do we know of their significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Characteristics of fasciculations in amyotrophic lateral sclerosis and the benign fasciculation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Electrodiagnostic criteria for diagnosis of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Fasciculations in motor neuron disease: discharge rate reflects extent and recency of collateral sprouting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Corticomotor threshold is reduced in early sporadic amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Fasciculation potentials in high-density surface EMG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Firing pattern of fasciculations in ALS: evidence for axonal and neuronal origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Ultrasonographic detection of fasciculations markedly increases diagnostic sensitivity of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Mutations in the gene-encoding SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+ ATPase, are associated with Brody disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American academy of neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Estimation of the frequency of the muscular pain-fasciculation syndrome and the muscular cramp-fasciculation syndrome in the adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Clofibrate-lnduced acute muscular syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Muscle cramps induced by beta-blockers with intrinsic sympathomimetic activity properties: a hint of a possible mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Angiotensin converting enzyme inhibitors and diuretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Muscle cramps during treatment with nifedipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Muscle cramp and oral salbutamol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Penicillamine-induced neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Neuromuscular manifestations of electrolyte disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Management of postpolio syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Redefining the clinical phenotypes of non-dystrophic myotonic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Absent, unrecognized, and minimal myotonic discharges in myotonic dystrophy type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

The clinical and electrodiagnostic characteristics of Pompe disease with post-enzyme replacement therapy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Differential diagnosis of myotonic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Hypothyroidism with true myotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Myotonia induced by clofibrate and sodium chlorophenoxy isobutyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Current overview of statin-induced myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Myotonia in colchicine myoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Health status in non-dystrophic myotonias: close relation with pain and fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

RNA-mediated neurodegeneration in repeat expansion disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

The nondystrophic myotonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Propagation disturbance of motor unit action potentials during transient paresis in generalized myotonia: a high-density surface EMG study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Caveolinopathies: from the biology of caveolin-3 to human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Severe autosomal recessive rippling muscle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Immune-mediated rippling muscle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Rippling muscle disease may be caused by "silent" action potentials in the tubular system of skeletal muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Acute myoedema: an unusual presenting manifestation of hypothyroid myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Myoedema in anorexia nervosa: a useful clinical sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Evidence for plateau potentials in tail motoneurons of awake chronic spinal rats with spasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Involuntary painful muscle contractions in Satoyoshi syndrome: a surface electromyographic study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Intravenous gammaglobulin therapy of Satoyoshi syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Maternal and neonatal tetanus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Neurotoxins affecting neuroexocytosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Gitelman's syndrome: towards genotype-phenotype correlations?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Isaacs' syndrome as a potassium channelopathy of the nerve

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

When is myokymia neuromyotonia?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Heterogeneity in Schwartz-Jampel chondrodystrophic myotonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz–Jampel syndrome neuromyotonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Cramps, muscle pain, and fasciculations: not always benign?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Fasciculation potentials in foot and leg muscles of healthy young adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Fasciculations and their F-response. Localisation of their axonal origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Neurophysiological features of fasciculation potentials evoked by transcranial magnetic stimulation in amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Complex fasciculations and their origin in amyotrophic lateral sclerosis and Kennedy's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Muscle cramps during hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

X-linked bulbospinomuscular atrophy (Kennedy's disease) masquerading as lead neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Electromyography guides toward subgroups of mutations in muscle channelopathies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Rippling muscle disease: variable phenotype in a family with five afflicted members

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Rippling muscle disease: a review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Acquired rippling muscle disease in association with myasthenia gravis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

31 March 2020

Rippling muscle disease

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Phenotypic variability in rippling muscle disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Mounding phenomenon: an experimental study in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Electrical silence of myoedema

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.226

Malignant and benign fasciculations

31 March 2020

1 reference

12 December 2020

AAEE glossary of terms in clinical electromyography

1 reference

12 December 2020

Myotonia precipitated by propranolol therapy

1 reference

12 December 2020

Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. 1962

1 reference

12 December 2020

Tetany due to hypomagnesemia induced by cisplatin and doxorubicin treatment for synovial sarcoma

1 reference

12 December 2020

Cramps, spasms and muscle stiffness

1 reference

12 December 2020

Stiff-man syndrome in a patient with Hodgkin's disease. An unusual paraneoplastic syndrome

1 reference

12 December 2020

Diagnosis and differential diagnosis of muscle cramps: a clinical approach

1 reference

12 December 2020

Gitelman's syndrome: a differential diagnosis of normocalcemic tetany.

1 reference

12 December 2020

American Association of Electrodiagnostic Medicine glossary of terms in electrodiagnostic medicine

1 reference

12 December 2020

10.1038/NRNEUROL.2011.226

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1027383364

0 references

1 reference